Back
Putnam PanAgora ESG Emerging Markets Equity ETF Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
15
PPEM
Putnam PanAgora ESG Emerging Markets Equity ETF
Last Price:
$19.11
Seasonality Move:
6.57%
Sell
27
NVO
Novo Nordisk A/S
Last Price:
$36.97
Seasonality Move:
12.55%
Sell
15
Putnam PanAgora ESG Emerging Markets Equity ETF (PPEM)
is a Sell
Is Putnam PanAgora ESG Emerging Markets Equity ETF a Buy, Sell or Hold?
-
The current Putnam PanAgora ESG Emerging Markets Equity ETF [PPEM] share price is $18.82. The Score for PPEM is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
PPEM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $36.98. The Score for NVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PPEM Stock Price Chart
What is Putnam PanAgora ESG Emerging Markets Equity ETF's stock price today?
-
The Putnam PanAgora ESG Emerging Markets Equity ETF share price today is $18.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PPEM is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $36.98Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
PPEM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.21 | Sell |
| Relative Strength Index (14 RSI): | 36.74 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.57 - 19.93) | Sell |
| Bollinger Bands (100): | (21.48 - 29.6) | Sell |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.87 | Sell |
| Relative Strength Index (14 RSI): | 39.83 | Sell |
| Chaikin Money Flow: | 14566902 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.41 - 38.59) | Sell |
| Bollinger Bands (100): | (39.84 - 55.48) | Sell |
PPEM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.66 | Buy |
| 20-day SMA: | 19.02 | Sell |
| 50-day SMA: | 23.58 | Sell |
| 200-day SMA: | 25.85 | Sell |
| 8-day EMA: | 18.76 | Buy |
| 20-day EMA: | 19.53 | Sell |
| 50-day EMA: | 22.14 | Sell |
| 200-day EMA: | 24.74 | Sell |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.4 | Buy |
| 20-day SMA: | 37.4 | Sell |
| 50-day SMA: | 44.19 | Sell |
| 200-day SMA: | 53.09 | Sell |
| 8-day EMA: | 36.61 | Buy |
| 20-day EMA: | 37.8 | Sell |
| 50-day EMA: | 42.18 | Sell |
| 200-day EMA: | 54.43 | Sell |
Putnam PanAgora ESG Emerging Markets Equity ETF Earnings Growth & PPEM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.05 per share.
Putnam PanAgora ESG Emerging Markets Equity ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||